Data Snapshot: Nov 03, 2026
<$50K

Oct-2026

Sales

Neutral

Trend

6-Month

6

Product Count

SKUs

$16.3

Avg Price

-40%

YoY Sales Change

3.1%

YoY Price Change

Ovis Pharmaceuticals is a trusted cannabis wellness brand based in Alberta, known particularly for its innovative range of medical cannabis products, including softgels, tablets, and topicals rich in THC, CBD, CBG, and CBN. The new yet already popular brand provides a holistic health approach, aiding its users' health journey, available for online ordering across several Canadian outlets. While it is still carving out its brand identity in the cannabis market, Ovis already has a solid following and partnerships in the industry, promising a future of growth and reliability.
How loyal are cannabis customers to the brands they buy? See retention benchmarks by category and state →
For brands

Is this your brand?

See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.

See your brand's data
For retailers

Carry this brand in your store?

Headset Retailer is free. Connect your POS and see what's selling and what's sitting.

Sign up free
Ovis Sales

Market Insights Snapshot

Ovis Historical Sales by Category

In October 2026, Ovis concentrated entirely in Capsules with a 100.0% category share, while year-over-year sales declined 40.0% and month-over-month sales increased 85.1%. Average price rose 3.1% YoY to $16.30, with zero mix outside Capsules and a rank of 9 in Alberta Capsules shaping visibility. The pattern implies the brand’s single-category reliance amplified volatility: a sharp October 2026 MoM rebound of 85.1% alongside a 40.0% YoY contraction suggests demand is elastic to short-term catalysts but lacks diversification to buffer year-level declines.

Given a 100.0% Capsules mix, the 9th-place rank and 3.1% YoY price lift indicate Ovis is competing on mid-pack positioning rather than price-led expansion, even as monthly demand surges 85.1% from September 2026 and trails by 40.0% versus October 2025. The implication is a need to convert MoM momentum within Capsules into sustained share capture in Alberta, because a single-category footprint magnifies the risk that another 40.0% YoY downdraft could erase the 85.1% MoM gain if promotional or seasonal lift fades.

Oct-2026 Rank
Capsules
#9
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Capsules
100.0%
$16.30
-40.0%
+85.1%
Ovis

Competitive Landscape

Ovis sits at #9 in AB Capsules in October 2026, a 1-place improvement from #10 year over year and a 2-place rise from #11 in July 2026, while still two spots below its peak of #7 from April 2025; in contrast, Glacial Gold advanced from #2 to #1 with 72.64% year-over-year sales growth and Tweed slid from #1 to #2 alongside a -73.88% year-over-year sales decline, indicating Ovis is gaining rank relative to weakening incumbents but not closing the gap to the category leader; this pattern implies Ovis’s gradual upward rank trajectory is being aided more by competitor deterioration than by breakout share capture, signaling a need to convert incremental rank gains into sustained share moves before competitive momentum reorders the top tier.

Ovis category ranking vs. nearest competitors
Ovis

Notable Products

Ovis sells a tightly concentrated capsules lineup in October 2026, with Hybrid softgels taking 88.4% of sales and two items, THC Softgel 15-Pack (150mg) and Blue THC Softgel 50-Pack (125mg), combining for 63.1%. There were 0 new products in the last six months, so most of its sales ride on a few established Hybrid softgels.

Product
Type
Share of Sales
Avg Price
vs. Peer Avg
MoM %
THC Softgel 15-Pack (150mg)
Hybrid
35.8%
$11.85
+0.0%
+97.7%
Blue THC Softgel 50-Pack (125mg)
Hybrid
27.3%
$27.19
+0.0%
+151.2%
CBG/CBD/THC 1:1:1 Softgels 15-Pack (75mg CBG, 75mg CBD, 75mg THC)
Hybrid
25.3%
$19.38
+17.4%
+22.8%
CBD/THC 1:1 Hybrid Balanced Capsules 15-Pack (150mg CBD, 150mg THC)
CBD / CBN
6.4%
$12.79
-16.8%
+45.9%
CBN Goftgels 10-Pack (200mg CBN)
CBD / CBN
3.0%
$14.99
—
—
CBD/THC 50:5 Softgels 15-Pack (750mg CBD, 75mg THC)
CBD / CBN
2.1%
$20.99
+0.0%
—

Peer avg: average price of the same product type and package size in the same states that month.

View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market